Josh Gottheimer · ABT
Josh Gottheimer's ABT trades
- Transactions
- 6
- Buys / sells
- 3 / 3
- Disclosed range
- $6K – $90K
- Last filed
- 2026-06-03
ABT transactions reported by Josh Gottheimer
| Type | Owner | ||||
|---|---|---|---|---|---|
Abbott Laboratories Common Stock ABT | Sale | Joint | $1,001 - $15,000 | 2026-06-03 #20034693 | |
Abbott Laboratories Common Stock ABT | Sale | Joint | $1,001 - $15,000 | 2025-08-11 #20030848 | |
Abbott Laboratories Common Stock ABT | Sale | Joint | $1,001 - $15,000 | 2025-04-10 #20029083 | |
Abbott Laboratories Common Stock ABT | Purchase | Joint | $1,001 - $15,000 | 2025-03-06 #20027901 | |
Abbott Laboratories Common Stock ABT | Purchase | Joint | $1,001 - $15,000 | 2025-02-10 #20026732 | |
Abbott Laboratories Common Stock ABT | Purchase | Joint | $1,001 - $15,000 | 2025-02-10 #20026732 |
A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.
The tracker is free
A STOCK Act row is evidence, not a model portfolio. Membership is the sourced monthly thesis around it.
Other House members who reported ABT
More tickers reported by Josh Gottheimer
Josh Gottheimer and ABT — questions
Did Josh Gottheimer buy or sell ABT?
House Clerk filings for 2025 and 2026 show 3 purchases and 3 sales of Abbott Laboratories (ABT) reported by Josh Gottheimer, between 2025-01-28 and 2026-05-27. Reported owner: Joint.
How much ABT did Josh Gottheimer trade?
Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $6K – $90K across 6 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.
When was the last ABT filing by Josh Gottheimer?
The most recent periodic transaction report containing a ABT row was filed on 2026-06-03. New filings appear in the House Clerk index and are picked up when the dataset is refreshed.
Yield Theory is not affiliated with any elected official or with Abbott Laboratories. Rows are parsed from public House Clerk periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.
Don’t copy the filing. Read the thesis.
Josh Gottheimer ABT disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $15/month or $150/year.
$15/mo or $150/yr · cancel future renewals anytime · sources included